-
Jim QIU
Equity Partner / Shanghai
-
Tel +86-21-6061-3666
Email jimqiu@zhonglun.com
-
Practices
Compliance & Investigation, Investment/M&A & Corporate Governance, Private Equity & Investment Funds
-
Industries
Telecommunications & Internet, Healthcare, Pharmaceuticals & Life Sciences
Jim QIU
JIM QIU is a partner from the practice groups of Compliance and Life Science & Healthcare of the firm and resident in the Shanghai office. Mr. Qiu has been dedicated to compliance and risk management services for various transactions and enterprises. He has extensive practice experience in enterprise compliance management and operation, analysis, control and mitigation of compliance risks, compliance review, compliance investigation and due diligence, as well as consultation and support on legal proceedings against compliance violation domestically and overseas.
Mr. Qiu has been serving on a long-term basis many multinational and domestic biotechnology, pharmaceutical, medical device, online medical service and third party medical service enterprises, medical institutions, medical affairs associations, etc. Mr. Qiu and his team’s practices cover the entire circle of the operation of healthcare and life science enterprises, such as industry access and supervision, licensing transaction, product R&D and clinical compliance, healthcare regulatory compliance, product marketing, academic activities, HCP interaction, pharmacovigilance, medical device adverse events, online healthcare, medical malpractice, etc. In addition to the healthcare sector, Mr. Qiu and his team also has good knowledge and experience in the fields of health food, cosmetics, food for specific medical purposes, infant formula food, pet food (including pet prescription food), etc.
Mr. Qiu is the long-term external counsel of all the medical associations and organizations in Shanghai, including Shanghai Medical Association, and also services as a special column writer for the compliance section of LexisNexis, a globally well-known publishing organization.
Representative Matters
Compliance and Regulatory in Medical Healthcare Industry
Provided daily and specific legal and compliance services to Sanofi on long-term basis on its China operations
Assisted and advised Merck Sharp & Dohme on long-term basis on its daily legal and compliance affairs relating to its China operations
Provided specific legal services for the R&D segment of BeiGene on long-term basis
Provided specific legal services and regulatory compliance advice for Roche with respect to the digital marketing business
Assisted United Imaging on the daily compliance affairs and contract matters
Provided legal and compliance advisory services for Stryker on long-term basis in connection with its daily operations
Provided long-term legal advice to Smith & Nephew on daily compliance-related affairs
Provided legal and compliance advisory service to Hoya/Pentax on its China operations
Provided legal and compliance service on long-term basis to the healthcare division of ByteDance
Provided legal and compliance advisory services on long-term basis to Tencent Healthcare Affairs Division
Provided legal and compliance services on long-term basis to DXY on its China operations
Provided daily legal services on long-term basis to the Management Office of All Shanghai Medical Associations (including Shanghai Medical Association, Shanghai Physician Association, Shanghai Chinese Medicine Association, Shanghai Nursing Association, etc.)
Assisted a U.S. based global pharmaceutical company on long-term basis in a number of cases regarding the adverse events across the nation
Represented a U.S. based pharmaceutical company in a drug quality dispute over adverse drug reactions and medical products
Represent a multinational pharmaceutical company in a lawsuit over indemnification disputes against subjects in multi-center clinical trials
Provided specific compliance advice to a multinational pharmaceutical company on the bid evaluation matters for centralized volume-based procurement of medicines
Provided specific compliance advice to a renowned Israeli medical devices company on the marketing pathway in China of an innovative drug and medical device combined product
Represent a Europe-based international pharmaceutical company in leading its nationwide anti-corruption program relating to bribery issues and improvement of its China compliance practices
Advised a U.S.- based international medical device company on its commercial bribery investigations across the nation
Compliance Sectors
Represented Anheuser-Busch InBev on compliance review and due diligence over a number of acquisition transactions in China
Assisted Anheuser-Busch InBev on long-term basis in its daily compliance review of new vendors
Advised Luyang Energy-Saving Materials Co., Ltd. (a listed company) on long-term basis on compliance and risk management in all respects of its China operations
Assisted many U.S. and Europe-based multinational companies in their China internal anti-bribery investigations and compliance programs
Advised many U.S. and Europe-based multinational companies on the potential compliance issues concerning their China distribution systems and sales incentive programs
Provided anti-corruption and anti-bribery training to many multinational and domestic companies and advised on the compliance improvement program for their China operations
Provided nationwide legal support and assistance to many U.S. and Europe-based multinational companies in governmental investigations on various compliance-related matters
Assisted a number of well-known U.S. and Europe-based manufacturing corporations in a nationwide anti-counterfeit program
Advised a Europe-based international pharmaceuticals company on investigations against its unfair competition violations across the nation;
Advised a well-known Europe-based cosmetic company in a governmental investigation and improvement program relating to a severe safety accident
Advised a well-known U.S.-based chemical company in a governmental investigation against its potential environmental violation issue
Honors and Awards
For Individual
Key Lawyers in Healthcare and Life Sciences Sector, Legal 500 Asia-Pacific 2020, 2021 & 2022,
Outstanding Writer of 2021, LexisNexis, (Compliance Sector)
China 100 A-list Lawyers, China Business Law Journal 2016
Memberships & Affiliations
Member of all China Law Society and Shanghai Law Society
Certified Dealmaker of the PRC
Member of Professional Committee of Pharmaceutical and Healthcare Affairs, Shanghai Law Society
Member of Life Science Law Committee, Shanghai Law Society
Member of Competition Law Committee, Shanghai Law Society
Legal Counsel of Shanghai Union Administration Office of Medical Affairs Organizations (the head office of Shanghai Medical Association, Shanghai Medical Doctor Association, Shanghai Association of Traditional Chinese Medicine, Shanghai Nursing Association, etc.)
Special column writer for the compliance section of LexisNexis
Expert consultant of the Supreme People’s Procuratorate (for civil and administrative cases)
Legal Counsel of Government of Songjiang District, Shanghai
Invited Mediator of Professional People's Mediation Center of Pudong New Area, Shanghai
Publications
“Research and Proposal on Medical Expenses Bearing System during Major Epidemics”, an awarded essay in the essay competition held by Healthcare Legal Service Special Group of All China Lawyers Association;
“Legitimate Handling of Medical Expenses During the Pandemic, selected in Compilation of Studies on Legal Issues Against the Pandemic in the Field of Medical and Healthcare by Medical and Health Committee of Shanghai Bar Association”, published on the website of Shanghai Bar Association;
“Supervision and Legal Risks Regarding Online Diagnosis and Treatment, LexisNexis, selected in The Great Health Industry: Policy, Trends, and Legal Innovations”, published by Law Press China;
“Updates for You: New Rules for Online Diagnosis and Hospital Management”, published on Wolters Kluwer
“Compliance Manual for Anti-Commercial Bribery Practices”, published on LexisNexis
Related
-
Articles Related
Data Collection and Processing: Health and Genetic Data (China)
An overview of the regulatory requirements for cybersecurity and data protection in the Chinese healthcare industry. It focuses on data compliance issues that might be encountered by pharmaceutical companies and medical institutions, in particular regarding the requirements on data localisation and cross-border transfers of various types of healthcare data, including sensitive personal information (PI), human genetic resources (HGR) data, clinical trial data, medical records, and so on.
2023-07-20 -
Events Related
-
Awards Related
114 Lawyers from 39 Practice Areas of Zhong Lun Recognized in Chambers Greater China Guide 2024
Zhong Lun Lawyers Garner 136 honors and 39 practice areas are recommended
2024-08-02
-
Bar Admissions/Professional Qualifications
PRC Bar
Certified Dealmaker of the PRC -
Education
LL.M., University of Minnesota Law School, Minnesota, U.S.
LL.B., East China University of Political Science and Law, Shanghai, China -
Languages
Chinese
English